ArticleNeuro-oncology practice2021

Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.

Theresa A Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.